Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey

References

• Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjær M, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006; 101: 1274–82
   PubMed Web of Science ®Google Scholar
• Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of Crohn's disease in four counties of southeastern Norway, 1990–93. A prospective population-based study. Scand J Gastroenterol 1996; 31: 355–61
   PubMed Web of Science ®Google Scholar
• Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990–93. A prospective population-based study. Scand J Gastroenterol 1996; 31: 362–6
   PubMed Web of Science ®Google Scholar
• Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804–10
   PubMed Web of Science ®Google Scholar
• Andersson P, Olaison G, Bendtsen P, Myrelid P, Sjödahl R. Health-related quality of life in Crohn's proctocolitis does not differ from a general population when in remission. Colorect Dis 2003; 5: 56–62
   PubMedGoogle Scholar
• Carty E, Rampton DS. Evaluation of new therapies for inflammatory bowel disease. Br J Clin Pharmacol 2003; 56: 351–61
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005; 128: 862–9
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462–76
   PubMed Web of Science ®Google Scholar
• Van Balkom BPJ, Schoon EJ, Stockbrugger RW, Wolters FL, van Hogezand RA, van Deventer SJH, et al. Effects of anti-tumour necrosis factor-α therapy on the quality of life in Crohn's disease. Aliment Pharmacol Ther 2002; 16: 1101–7
   PubMed Web of Science ®Google Scholar
• McLeod RS, Lavery IC, Leatherman JR, Maryland PA, Fazio VW, Jagelman DG, et al. Factors affecting quality of life with a conventional ileostomy. World J Surg 1986; 10: 474–9
   PubMed Web of Science ®Google Scholar
• Michelassi F, Lee J, Rubin M, Fichera A, Kasza K, Karrison T, et al. Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis. Ann Surg 2003; 238: 433–45
   PubMed Web of Science ®Google Scholar
• Turina M, Pennington CJ, Kimberling J, Stromberg AJ, Petras RE, Galandiuk S. Chronic pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: effect on quality of life. J Gastroent Surg 2006; 10: 600–6
   PubMedGoogle Scholar
• Delaney CP, Remzi FH, Gramlich T, Dadvand B, Fazio VW. Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis. Ann Surg 2002; 236: 43–8
   PubMedGoogle Scholar
• Canavan C, Abrams KR, Hawthorne B, Drossman D, Mayberry JF. Long-term prognosis in Crohn's disease: factors that affect quality of life. Aliment Phamacol Ther 2006; 23: 377–85
   PubMed Web of Science ®Google Scholar
• Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn's Colitis 2007; 1: 10–20
   Google Scholar
• Halme L, Turunen U, Heliö T, Paavola P, Walle T, Miettinen A, et al. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogenous population. Scand J Gastroenterol 2002; 37: 692–8
   PubMed Web of Science ®Google Scholar
• Kaipiainen-Seppänen O, Aho K, Heliövaara M. Incidence and prevalence of ankylosing spondylitis in Finland. J Rheumatol 1997; 24: 496–9
   PubMed Web of Science ®Google Scholar
• Aho K, Kaipiainen-Seppänen O, Heliövaara M, Klaukka T. Epidemiology of rheumatoid arthritis in Finland. Semin Arthritis Rheum 1998; 27: 325–34
   PubMed Web of Science ®Google Scholar
• Schwartz DA, Loftus EV, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875–80
   PubMed Web of Science ®Google Scholar
• Travis SPL, Stange EF, Lémann M, Öresland T, Chowers Y, Forbes A, et al. European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006; 55(Suppl I)i16–i35
   PubMedGoogle Scholar
• Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99: 956–63
   PubMed Web of Science ®Google Scholar
• Thirlby RC, Sobrino MA, Randall JB. The long-term benefit of surgery on health-related quality of life in patients with inflammatory bowel disease. Arch Surg 2001; 136: 521–7
   PubMedGoogle Scholar